share_log
Moomoo 24/7 ·  Feb 6 15:38
Immunome Shares Are Trading Higher After the Company Announced That It Entered Into a Definitive Asset Purchase Agreement With Ayala Pharmaceuticals to Acquire AL102 and AL101 Drug Candidates
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment